María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Dana–Farber Cancer Institute (2)
2022
-
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2506-2516
2017
-
Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: The SELECT-1 randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 317, Núm. 18, pp. 1844-1853